RRC ID 38997
著者 Terai S, Noma T, Kimura T, Nakazawa A, Kurokawa F, Okita K.
タイトル Wild-type p53 gene-induced morphological changes and growth suppression in hepatoma cells.
ジャーナル J Gastroenterol
Abstract The human hepatocellular carcinoma (HCC) cell line, HLF, expresses only mutant-type p53 (mt-p53), which has an amino acid substitution at the 244th residue from glycine to alanine. HLF cells were transfected with wild-type p53 (wt-p53) cDNA construct pC53-SN3, mt-p53 cDNA construct pC53-SCX [which differs by a single nucleotide, resulting in alanine instead of valine at the 143rd residue in p53 (p53-143)], or pCMV-Neo-Bam, as a control, by a liposome method. After G418 selection, three wt-p53 stable transformants (WT), four mt-p53 transformants (MT), and three control vector transformants (VT) were obtained. We analyzed the cell growth and morphological changes of these transformants under different culture conditions [fetal calf serum (FCS), 10%, 1%, and 0%]. Whereas no difference from control in the growth rate and morphology was observed under the 10% FCS conditions, serum starvation induced remarkable phenotypical changes in all three WTs, but not in the other transformant. Corresponding to these phenotypical changes, the transcriptional activity of wt-p53 was increased more than nine fold. These results indicated that serum starvation would induce wt-p53 biological function, which is tightly linked to morphological changes and growth suppression. To induce these changes, the introduction of the wt-p53 gene itself was not sufficient, and additional triggering, i.e., serum starvation, was indispensable.
巻・号 32(3)
ページ 330-7
公開日 1997-6-1
DOI 10.1007/BF02934489
PMID 9213246
MeSH Carcinoma, Hepatocellular / genetics Carcinoma, Hepatocellular / pathology* Genes, p53 / physiology* Humans Liver Neoplasms / genetics Liver Neoplasms / pathology* Phenotype Transcription, Genetic Transfection Tumor Cells, Cultured Tumor Suppressor Protein p53 / metabolism
IF 6.132
引用数 4
WOS 分野 GASTROENTEROLOGY & HEPATOLOGY
リソース情報
ヒト・動物細胞 Hep G2(RCB0459)